Overview

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

Status:
Completed
Trial end date:
2016-12-21
Target enrollment:
Participant gender:
Summary
The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.
Details
Lead Sponsor:
Servier Hellas Pharmaceuticals Ltd.
Treatments:
Amlodipine
Indapamide
Perindopril